An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer

Abstract Background An accurate genotyping analysis is one of the critical prerequisites for patients with colorectal cancer receiving matched therapies. Conventional genotyping analysis is currently used to detect either gene mutations or MSI status, delaying the detection of critical tumor biomark...

Full description

Bibliographic Details
Main Authors: Li Liang, Xin Li, Lin Nong, Weijing Cai, Jixin Zhang, Ping Liu, Ting Li
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5557
_version_ 1797838388439547904
author Li Liang
Xin Li
Lin Nong
Weijing Cai
Jixin Zhang
Ping Liu
Ting Li
author_facet Li Liang
Xin Li
Lin Nong
Weijing Cai
Jixin Zhang
Ping Liu
Ting Li
author_sort Li Liang
collection DOAJ
description Abstract Background An accurate genotyping analysis is one of the critical prerequisites for patients with colorectal cancer receiving matched therapies. Conventional genotyping analysis is currently used to detect either gene mutations or MSI status, delaying the detection of critical tumor biomarkers and thus the optimal time for treatment. An assay that analyzes both biomarkers in a streamlined process is eagerly needed. Methods We developed an assay combining Multiplex PCR Amplification, Single‐base Extension and capillary electrophoresis (CE) analysis (MASE‐CE) for synchronous detection of KRAS/NRAS/BRAF mutations and MSI status. In a 190 colorectal cancer cohort, we identified seven somatic mutations in KRAS, NRAS and BRAF as well as five MSI loci (D2S123/D5S346/D17S250/BAT‐25/BAT‐26) simultaneously. KRAS/NRAS/BRAF mutations were detected by NGS and MASE‐CE, and MSI status were detected by PCR‐CE and MASE‐CE methods. Results The MASE‐CE method showed high consistency with NGS for mutation detection (Kappa value ≥0.8) and PCR‐CE (Kappa value = 0.79). In addition, the limits of detection (LOD) of MASE‐CE assay for MSI and somatic mutation were 5% and 2%, respectively. Conclusions In somatic mutation detection and MSI detection, the LOD of MASE‐CE assay was superior to that of qPCR and NGS. MASE‐CE assay is a highly sensitive, time‐saving and specimen‐saving method, which can greatly avoid the cumbersome testing process and provide clinical decision for doctors in time.
first_indexed 2024-04-09T15:41:02Z
format Article
id doaj.art-a371370838444350ab96e824c4e24165
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-09T15:41:02Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-a371370838444350ab96e824c4e241652023-04-27T10:12:43ZengWileyCancer Medicine2045-76342023-04-011278367837710.1002/cam4.5557An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancerLi Liang0Xin Li1Lin Nong2Weijing Cai3Jixin Zhang4Ping Liu5Ting Li6Peking University First Hospital Beijing ChinaPeking University First Hospital Beijing ChinaPeking University First Hospital Beijing ChinaShanghai Tongshu Biotechnology Co., Ltd Shanghai ChinaPeking University First Hospital Beijing ChinaPeking University First Hospital Beijing ChinaPeking University First Hospital Beijing ChinaAbstract Background An accurate genotyping analysis is one of the critical prerequisites for patients with colorectal cancer receiving matched therapies. Conventional genotyping analysis is currently used to detect either gene mutations or MSI status, delaying the detection of critical tumor biomarkers and thus the optimal time for treatment. An assay that analyzes both biomarkers in a streamlined process is eagerly needed. Methods We developed an assay combining Multiplex PCR Amplification, Single‐base Extension and capillary electrophoresis (CE) analysis (MASE‐CE) for synchronous detection of KRAS/NRAS/BRAF mutations and MSI status. In a 190 colorectal cancer cohort, we identified seven somatic mutations in KRAS, NRAS and BRAF as well as five MSI loci (D2S123/D5S346/D17S250/BAT‐25/BAT‐26) simultaneously. KRAS/NRAS/BRAF mutations were detected by NGS and MASE‐CE, and MSI status were detected by PCR‐CE and MASE‐CE methods. Results The MASE‐CE method showed high consistency with NGS for mutation detection (Kappa value ≥0.8) and PCR‐CE (Kappa value = 0.79). In addition, the limits of detection (LOD) of MASE‐CE assay for MSI and somatic mutation were 5% and 2%, respectively. Conclusions In somatic mutation detection and MSI detection, the LOD of MASE‐CE assay was superior to that of qPCR and NGS. MASE‐CE assay is a highly sensitive, time‐saving and specimen‐saving method, which can greatly avoid the cumbersome testing process and provide clinical decision for doctors in time.https://doi.org/10.1002/cam4.5557colorectal cancerMASE‐CEMSIsingle‐base extensiontimesaver
spellingShingle Li Liang
Xin Li
Lin Nong
Weijing Cai
Jixin Zhang
Ping Liu
Ting Li
An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer
Cancer Medicine
colorectal cancer
MASE‐CE
MSI
single‐base extension
timesaver
title An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer
title_full An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer
title_fullStr An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer
title_full_unstemmed An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer
title_short An innovative single‐base extension method for synchronous detection of point mutations and MSI status in colorectal cancer
title_sort innovative single base extension method for synchronous detection of point mutations and msi status in colorectal cancer
topic colorectal cancer
MASE‐CE
MSI
single‐base extension
timesaver
url https://doi.org/10.1002/cam4.5557
work_keys_str_mv AT liliang aninnovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT xinli aninnovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT linnong aninnovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT weijingcai aninnovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT jixinzhang aninnovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT pingliu aninnovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT tingli aninnovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT liliang innovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT xinli innovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT linnong innovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT weijingcai innovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT jixinzhang innovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT pingliu innovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer
AT tingli innovativesinglebaseextensionmethodforsynchronousdetectionofpointmutationsandmsistatusincolorectalcancer